Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

You make some good points but I never suggested malpractice. I just believe his tenure as CEO at Apricus was too short and he left as the stock was dropping.

The current number of shares at this stage is in excess. It will take revenue of around $30-40M with a min of 0.05 earnings/share to boost this stock. This mean, assuming 150M O/S, earnings would have to be around $7.5M. Quite frankly, I don't see that happening on the earnings side. Without Fluticare (possibly contributing $15M), this stock will be in trouble as far as pps.$15M in revenues won't cut it based on the dilution.